Ginkgo biloba

Generic Name
Ginkgo biloba
Brand Names
-
Drug Type
Biotech
Chemical Formula
-
CAS Number
90045-36-6
Unique Ingredient Identifier
19FUJ2C58T
Background

Ginkgo biloba extract contains a group of terpene lactones (notably, ginkgolides and diterpenes) and ginkgo flavone glycosides (notably, ginkgetin, bilobetin, and sciadopitysin) that have antioxidant and vasoactive properties. Most of the studies that investigate the effect of ginkgo biloba use the standardized extract of Ginkgo biloba (EGb) 761 (EGb761), wh...

Indication

Ginkgo biloba does not currently have any approved therapeutic indications, and there is insufficient evidence to support its unapproved use. It is available in over-the-counter herbal products mostly for oral use, to improve memory and cognitive problems.

Associated Conditions
Cognitive Dysfunctions, Cognitive Functioning, Depression
Associated Therapies
-

Effects of Ginseng and Ginkgo on Drug Disposition in Man

Phase 2
Completed
Conditions
First Posted Date
2002-01-21
Last Posted Date
2006-07-26
Lead Sponsor
National Center for Complementary and Integrative Health (NCCIH)
Target Recruit Count
60
Registration Number
NCT00029692
Locations
🇺🇸

University of Kansas Medical Center, Kansas City, Kansas, United States

Ginkgo Biloba Prevention Trial in Older Individuals

First Posted Date
2001-02-05
Last Posted Date
2013-03-14
Lead Sponsor
National Center for Complementary and Integrative Health (NCCIH)
Target Recruit Count
3069
Registration Number
NCT00010803
Locations
🇺🇸

Johns Hopkins University, Baltimore, Maryland, United States

🇺🇸

University of Pittsburgh, Pittsburgh, Pennsylvania, United States

🇺🇸

University of California, Davis, Sacramento, California, United States

and more 2 locations

Preventing Cognitive Decline With Alternative Therapies

Phase 3
Completed
Conditions
First Posted Date
2001-02-05
Last Posted Date
2006-08-18
Lead Sponsor
National Center for Complementary and Integrative Health (NCCIH)
Registration Number
NCT00010920
Locations
🇺🇸

Oregon Health Sciences University/Neurology, Portland, Oregon, United States

Natural Antioxidants in the Treatment of Multiple Sclerosis

Phase 1
Completed
Conditions
First Posted Date
2001-02-05
Last Posted Date
2006-08-18
Lead Sponsor
National Center for Complementary and Integrative Health (NCCIH)
Registration Number
NCT00010842
Locations
🇺🇸

Oregon Health Sciences University, Portland, Oregon, United States

© Copyright 2024. All Rights Reserved by MedPath